When was Lexogen founded?

Lexogen was founded in 2007 and raised its 1st funding round 13 years after it was founded.

Where is Lexogen located?

Lexogen is headquartered in Vienna, Austria.

How many employees does Lexogen have?

As of Jul 31, 2026, the latest employee count at Lexogen is 60.

Is Lexogen a funded company?

Lexogen is a funded company, having raised a total of $***** in its 1st and only funding round, a PE round on Apr 29, 2020.

When was the latest funding round of Lexogen?

Lexogen's latest funding was a $***** PE round on Apr 29, 2020, with participation from 1 investor. Its primary sector is Genomics. Globally, the Genomics sector has seen $2.44B in funding in 2026 to date.

Where does Lexogen rank among its competitors?

Lexogen ranks 32nd amongst 659 active competitors, of which 108 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Genomenon, which secured $6.03M in Jul, 2026.

Who are the top competitors of Lexogen?

Lexogen's top competitors include DNAnexus, Fabric Genomics and Twin Strand Bio. Among them, Genomenon secured the most recent funding round in July, 2026.

Lexogen - 2026 Company Profile, Funding & Competitors

Company Details

Lexogen has developed expression profiling methods that enable detailed analysis of the complete transcriptome as well as individual full-length RNAs of interest. Its product portfolio includes expression profiling library prep kits (for Illumina, Ion Torrent); Whole transcriptome library prep kits; kits for RNA isolation and cDNA amplification, and other for barcoding, PCR etc. Also provides software for RNA-Seq data analysis.

Website: lexogen.com
Social
Email ID: *****@lexogen.com

Key Metrics

Founded Year

2007

Location

Vienna, Austria

Stage

Late Stage

Latest Funding Round

PE, Apr 29, 2020, $*****

Investors

FFG & 2 more

Ranked

32^nd among 659 active competitors

Employee Count

60 as on Jul 31, 2026

Similar Companies

DNAnexus & 829 more

View Lexogen's full profile

Lexogen has raised funding over 1 round. Its latest funding round was a PE round on Apr 29, 2020 for $*****. 1 investor participated in its latest round. Lexogen has 3 institutional investors.

Here is the list of recent funding rounds of Lexogen:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 29, 2020	1276322	PE	2407385	3524853	2756344	3532193

Access funding benchmarks and valuations. Sign up today!

View details of Lexogen's funding rounds and investors

Lexogen's employee count trend

Lexogen has 60 employees as of Jul 26. Here is Lexogen's employee count trend over the years:

Uncover Lexogen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lexogen include DNAnexus, Fabric Genomics and Twin Strand Bio. Here is the list of Top 10 competitors of Lexogen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	DNAnexus 2009, Mountain View (United States), Series H	Provider of cloud-based genome informatics & data management platform	$473M	Google Ventures, TPG & 21 others	71/100
2nd	Fabric Genomics 2009, Oakland (United States), Acquired	AI-based disease diagnosis and genomic analysis tool for providers	$32.8M	UPMC, LDV Partners & 12 others	67/100
3rd	Twin Strand Bio 2015, Seattle (United States), Series B	Developer of DNA sequencing technology to identify genomic mutations	$84M	S32, Madrona & 9 others	65/100
4th	LGC 1842, Teddington (United Kingdom), Acquired	Provider of analytical testing, reference materials, and diagnostic and therapeutic products	-	Broad Vision Funds, AlpInvest Partners & 4 others	65/100
5th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, True Ventures & 16 others	62/100
6th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Two Sigma Ventures & 10 others	62/100
7th	seqWell 2014, Beverly (United States), Series C	Provider of NGS-based reagents and kits for life sciences research	$24.5M	RCT, Codexis & 3 others	60/100
8th	Genomenon 2014, Ann Arbor (United States), Series C	Provider of software, data, and services for genomic information analysis	$42.9M	Michigan Rise, Spring Mountain Capital & 19 others	58/100
9th	BC Platforms 1997, Zurich (Switzerland), Series D	Provider of a platforms for genomic data analysis and management	$47.1M	Jolt Capital, Debiopharm & 6 others	58/100
10th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Elaia, Omnes Capital & 7 others	57/100
32nd	Lexogen 2007, Vienna (Austria), Late Stage	Provider of kits and software that enable detailed analysis of the complete transcriptome	-	FFG, Vienna Business Agency & 1 others	47/100